Literature DB >> 24277658

Focal 18F-FDG uptake in bone marrow on PET/CT in a patient with JAK2 mutation without overt myeloproliferative neoplasm.

Akihito Fujimi1, Yuji Kanisawa, Shinya Minami, Yusuke Kamihara, Sari Iwasaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24277658     DOI： 10.1007/s12185-013-1473-y

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  3 in total

1.  F-18 FDG PET in a patient with polycythemia vera.

Authors:  Henriette M E Quarles van Ufford; Jeroen A F de Jong; Henk J Baarslag; Marie J de Haas; Karen Oud; John M H de Klerk
Journal:  Clin Nucl Med       Date:  2008-11       Impact factor: 7.794

2.  The JAK2 V617F somatic mutation, mortality and cancer risk in the general population.

Authors:  Camilla Nielsen; Henrik S Birgens; Børge G Nordestgaard; Lasse Kjaer; Stig E Bojesen
Journal:  Haematologica       Date:  2010-12-15       Impact factor: 9.941

Review 3.  Genetic and epigenetic alterations of myeloproliferative disorders.

Authors:  Jelena D Milosevic; Robert Kralovics
Journal:  Int J Hematol       Date:  2012-12-12       Impact factor: 2.490
  3 in total
  1 in total

1.  A Pilot Study of FDG-PET/CT in Polycythemia Vera Using Global Analysis Techniques.

Authors:  Cyrus Ayubcha; Hitomi Hosoya; Siavash Mehdizadeh Seraj; Mahdi Zirakchian Zadeh; Thomas Werner M S E; Abass Alavi
Journal:  Asia Ocean J Nucl Med Biol       Date:  2020
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.